Pharmacist support 24/7

Select Language

Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Manufacturer: ELI LILLY AND COMPANY INDIA PVT LTD

Salt: TIRZEPATIDE-7.5MG

Category: Weight-Loss, Anti-Diabetic

Price: $265

Availability: In Stock

Mounjaro 7.5mg KwikPen is a once-weekly prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that belongs to a newer class of medicines called incretin mimetics. This medication helps improve blood sugar levels when diet and exercise alone are not enough.


Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 7.5mg pen holds a total of 30mg of tirzepatide (4 doses x 7.5mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.


This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider. Mounjaro 7.5 mg in India is available through select pharmacies and online medical suppliers, with prices varying depending on the seller and location.

Improving blood sugar control in adults with type 2 diabetes mellitus


Used in combination with diet and exercise


May be used alone or with other diabetes medications


It is not approved for weight loss or for use in type 1 diabetes.

In Stock
Mounjaro Tirzepatide 7.5mg Kwik Pen 1's
(4.8/5) 124 reviews
Medically Reviewed
Pharmacist Verified

Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

ManufacturerELI LILLY AND COMPANY INDIA PVT LTD
Salt CompositionTIRZEPATIDE-7.5MG
Weight LossAnti Diabetic
Sale Price
$265$320.65
21% OFF
1

Product Information

What is Mounjaro Tirzepatide 7.5mg Kwik Pen 1's?

Mounjaro 7.5mg KwikPen is a once-weekly prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that belongs to a newer class of medicines called incretin mimetics. This medication helps improve blood sugar levels when diet and exercise alone are not enough.


Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 7.5mg pen holds a total of 30mg of tirzepatide (4 doses x 7.5mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.


This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider. Mounjaro 7.5 mg in India is available through select pharmacies and online medical suppliers, with prices varying depending on the seller and location.

Indications for Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Improving blood sugar control in adults with type 2 diabetes mellitus


Used in combination with diet and exercise


May be used alone or with other diabetes medications


It is not approved for weight loss or for use in type 1 diabetes.

Therapeutic Effects of Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Tirzepatide in this pen works like two natural hormones in your body. These hormones help lower blood sugar in three ways — by helping your body release insulin when needed, stopping your liver from making too much sugar, and slowing down how quickly food leaves your stomach. This helps you feel full for longer and can reduce how much you eat. All of this helps keep your blood sugar steady throughout the day.

How to consume Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Inject once weekly into your abdomen, thigh, or upper arm, with or without food, at any time of the day. Always try to use it on the same day each week.


Remember:


Each pen has four doses of its stated strength (7.5mg pen = total 30mg in pen).


One dose per week means one pen is a one-month supply.


Never share your pen.


Rotate injection sites to avoid skin thickening.

Side Effects of Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Nausea


Vomiting


Diarrhea


Constipation


Decreased appetite


Injection site reactions (redness, itching)


Pancreatitis (severe abdominal pain)


Gallbladder issues (pain in the upper right abdomen)


Allergic reactions (rash, swelling, difficulty breathing)


Kidney problems due to dehydration from vomiting or diarrhea


Thyroid tumors (rare but serious; watch for neck swelling or hoarseness)

Drug Interactions

Like most diabetes medications, this injection can interact with certain other drugs and affect how well it works or increase the risk of side effects. Inform your doctor about all the medicines you take, especially:


Insulin or sulfonylureas: When taken together, the risk of low blood sugar increases. Dose adjustments may be needed.


Oral contraceptives: Tirzepatide may reduce the effectiveness of birth control pills due to delayed gastric emptying. Alternative or additional contraceptive methods are advised.


Warfarin: May affect INR levels. Close monitoring is essential if you are on blood thinners.


Diuretics or antihypertensives: Sudden drops in blood pressure may occur, especially if dehydration happens due to nausea or vomiting.


Thyroid medications: Use caution in patients with a history of thyroid issues, particularly medullary thyroid carcinoma.


Always carry a list of your medications to share with your doctor or pharmacist to prevent serious interactions.

Storage & Handling

Unused KwikPens


Keep unused KwikPens in the fridge at 2°C to 8°C—not in the freezer.


They’re good to use till the expiry date if kept refrigerated.


Never freeze the pen. If it gets frozen, throw it away in a sharps disposal container.


Store in original carton to protect from light.


After You Start Using a KwikPen


You can keep it at room temperature (up to 30°C) for up to 30 days.


Store away from direct heat and sunlight.


Throw it away 30 days after first use, even if there’s some medicine left.


Also discard after you’ve taken all 4 weekly doses in a sharps disposal container.

Expert Advice

Inject in a different spot each time to avoid skin thickening.


Avoid skipping doses; set reminders for your weekly injection.


Stay hydrated, especially if experiencing vomiting or diarrhea.


Eat balanced meals and monitor your blood sugar regularly.


Do not use the pen if it has been frozen or left out for too long.

Worldwide Shipping & Delivery

We provide specialized tracked delivery for Mounjaro Tirzepatide 7.5mg Kwik Pen 1's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.

  • USA Shipping
  • UK Delivery
  • UAE & Middle East
  • Germany & EU
  • Australia
  • Canada

Professional Safety Guidelines for Mounjaro Tirzepatide 7.5mg Kwik Pen 1's

Pregnancy
Pregnancy
Consult your doctor

Mounjaro 7.5mg KwikPen is not recommended during pregnancy due to limited human data. Animal studies show potential harm.

BreastFeeding
BreastFeeding
Consult your doctor

It is unknown whether tirzepatide passes into breast milk. Mounjaro 7.5mg KwikPen should only be used if clearly needed.

Liver
Liver
Consult your doctor

Mounjaro 7.5mg KwikPen should be used cautiously in people with liver conditions. Regular liver function monitoring may be required.

Lungs
Lungs
Safe

Mounjaro 7.5mg KwikPen is not known to affect the lungs directly, but if you have respiratory conditions, inform your doctor before use.

Alcohol
Alcohol
Unsafe

Drinking alcohol while using Mounjaro 7.5mg KwikPen may increase the risk of low blood sugar. Limit alcohol intake.

Driving
Driving
Consult your doctor

Mounjaro 7.5mg KwikPen can occasionally cause low blood sugar, which may impair focus or coordination while driving.

Similar Medications

View All